Brunei Launches National Cardiovascular Disease Prevention Programme with CARDIO4Cities
Annual government session brings legislators into direct contact with healthcare technology infrastructure supporting national digital health initiatives
BANDAR SERI BEGAWAN, 26 January 2026 – The Ministry of Health Brunei Darussalam, EVYD Technology, and the Novartis Foundation have signed a tw-year partnership to implement CARDIO4Cities – a proven population health program that has reduced stroke and heart attack rates in cities across three continents.
Cardiovascular disease remains Brunei’s leading cause of death, claiming 572 lives in 2024. The CARDIO4Cities will tackle four major risk factors – hypertension, diabetes, obesity, and hyperlipidaemia – making Brunei the first country to implement CARDIO4Cities with this expanded scope, in alignment with BruMAP-NCD 2021-2025.
What Will CARDIO4Cities Do in Brunei?
The national program focuses on four key interventions designed to shif cardiovascular care from reactive treatment to proactive prevention:
1. Nationwide Cardiovascular Screening
Cardiovascular screening will be deployed at all primary health facilities, and pharmacies across Brunei, expanding access to early risk detection for hypertension, diabetes, obesity, and high cholestrol.
2. Standardized Clinical Guidelines for Healthcare Providers
Healthcare providers will receive standardized clinical guidelines and decision-support tools based on international best practices, ensuring consistent, evidence-baseed cardiovascular care nationwide.
3. Real-Time Data Dashboards
Real-time dashboards will track cardiovascular disease detection, treatment, and control rates across the population, enabling data-driven decision-making and continuous program optimization.
4. Multi-Sector Streering Committee
A multi-sector steeering committee will set national targets for cardiovascular health and guide iterative improvements based on real-world outcomes data.
How Effective is CARDIO4Cities? Proven Results from Global Implementation
CARDIO4Cities has demonstrated measurable population-level impact in three major cities:
- São Paulo, Brazil
- Dakar, Senegal
- Ulaanbaatar, Mongolia
Within 15-21 months of implementation, these cities achieved:
- 3-6x increase in blood pressure control rates
- Up to 13% reduction in stroke incidence
- Up to 12% reduction in heart attack rates
The partnership aims to achieve simialr population-level outcomes tailored to Brunei’s epidemiological profile, with interventions designed to address the specific cardiovascularisk patterns observed in the Bruneian population.
EVYD Technology’s Role: Building the Data Foundation
EVYD Technology, which co-developed BruHealth in partnership with the Ministry of Health, will provide critical data integration and analytics support for the CARDIO4Cities program.
The partners will explore leveraging BruHealth – Brunei’s national digital platform – for cardiovascular risk stratification, enabling population-level monitoring and targeted intervention delivery.
“Our role is to ensure the programme is built on solid data foundations – so interventions can be measured, evaluated, and continuously improved,” said Abby Tan, General Manager of EVYD Technology.
When will CARDIO4Cities Launch in Brunei?
The two-year program is expected to commence in January 2026, with phased implementations across Brunei’s healthcare facilities.
About EVYD Technology
EVYD Technology is a Southeast Asia-based healthcare technology company with a vision to build a future where everyone can access better health. We leverage our deep expertise in healthcare data processing and AI to enable our partners to gain insights for informed decision making in healthcare and implement personalized health promotion, risk assessment and chronic disease management programmes at scale to improve population health outcomes.
Leave a comment
You must be logged in to post a comment.